Who is sponsoring NCT03224169?

NCT03224169 is sponsored by The University of Hong Kong.

What drugs are being tested in NCT03224169?

Interventions in NCT03224169: Directly observed hand hygiene.

What condition does NCT03224169 study?

NCT03224169 studies Multidrug Resistant Organisms.

Is NCT03224169 still recruiting?

NCT03224169 is currently status unknown. Last updated 21 July 2017.

Last reviewed 2017-07-21 · How we verify

NCT03224169

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementation of Directly Observed Hand Hygiene in Residential Care Home for the Elderly: a Cluster Randomized Trial

Status unknown NA Last updated 21 July 2017

What this trial tests

NA trial testing Directly observed hand hygiene in Multidrug Resistant Organisms in 200 participants. Status unknown.

Timeline

18 July 2017

Primary endpoint
30 August 2017

30 December 2017

Quick facts

Lead sponsor	The University of Hong Kong
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	200
Start date	18 July 2017
Primary completion	30 August 2017
Estimated completion	30 December 2017
Sites	1 location across Hong Kong

Drugs / interventions tested

Directly observed hand hygiene

Conditions studied

Multidrug Resistant Organisms — all drugs for Multidrug Resistant Organisms →

Sponsor

The University of Hong Kong

Who can join

Eligibility, any sex, with Multidrug Resistant Organisms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To screen the prevalence of multidrug resistant organisms among the resident in the residential care home for the elderly, and assess the practicability of directly observed hand hygiene in this setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03224169 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 21 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03224169.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing